Range Low Price High Price Comment
30 days $4.75 $8.82 Wednesday, 1st May 2024 BNTC stock ended at $7.90. This is 6.51% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 16.82% from a day low at $7.55 to a day high of $8.82.
90 days $2.70 $8.82
52 weeks $0.161 $8.82

Historical Benitec Biopharma Limited prices

Date Open High Low Close Volume
Feb 03, 2016 $3.95 $3.95 $3.66 $3.67 700
Feb 02, 2016 $3.65 $3.65 $3.50 $3.50 700
Feb 01, 2016 $3.60 $3.80 $3.49 $3.54 7 500
Jan 29, 2016 $3.85 $3.86 $3.56 $3.59 13 700
Jan 28, 2016 $3.75 $3.79 $3.65 $3.71 900
Jan 27, 2016 $3.75 $3.94 $3.49 $3.57 10 600
Jan 26, 2016 $3.90 $3.93 $3.58 $3.58 16 000
Jan 25, 2016 $4.02 $4.10 $3.82 $3.90 25 600
Jan 22, 2016 $3.85 $3.85 $3.80 $3.80 5 200
Jan 21, 2016 $3.79 $3.79 $3.57 $3.57 22 400
Jan 20, 2016 $3.91 $3.91 $3.79 $3.79 3 800
Jan 19, 2016 $4.11 $4.17 $3.91 $3.93 12 600
Jan 15, 2016 $4.34 $4.34 $3.92 $4.02 4 700
Jan 14, 2016 $4.17 $4.30 $4.17 $4.27 6 700
Jan 13, 2016 $4.05 $4.09 $3.90 $3.90 2 200
Jan 12, 2016 $4.01 $4.06 $4.01 $4.06 500
Jan 11, 2016 $4.12 $4.29 $3.95 $3.94 3 600
Jan 08, 2016 $4.08 $4.08 $3.95 $4.05 2 500
Jan 07, 2016 $4.15 $4.15 $3.84 $3.84 9 600
Jan 06, 2016 $4.05 $4.05 $4.05 $4.05 0
Jan 05, 2016 $4.31 $4.31 $3.89 $4.05 8 600
Click to get the best stock tips daily for free!

About Benitec Biopharma Limited

Benitec Biopharma Limited Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company w... BNTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT